Mestastop Solutions starts collaboration with IBAB, Bangalore to create novel animal models for metastasis

Brand Story
07 Apr 2023

Mestastop Solutions and the Institute of Bioinformatics and Applied Biotechnology (IBAB), Bengaluru, have inked an agreement to foster cooperation on several research initiatives of shared interest. According to this agreement, Mestastop joint research projects that call for the use of animals will be carried out at the IBAB animal house, subject to mutual understanding and the facility's suitability as determined by IBAB.

The founder and director of Mestastop, Dr Arnab Roy Chowdhury, said on the partnership: 'IBAB, which has excellent research facilities, expertise in the area of disease biology and drug discovery, is on the same site as the Bangalore Bioinnovation Centre, which incubates us. Therefore, joining hands felt intuitive and natural. We have developed one of the most intriguing animal models for metastasis, and thanks to this cooperative arrangement, we will develop many more. Together, we can influence change'.

The relationship was also discussed by Dr. H.S. Subramanya, director of IBAB: 'Mestastop Solutions is a deep-dive biotech start-up focused on cancer metastasis, which is responsible for 90% of cancer deaths. Mestastop contends that metastasis, a complicated process, must be targeted if an evolutionary disease like cancer is to be comprehensively combated. The partnership between IBAB and Mestastop will offer a fantastic chance to create new platforms and tools for studying and addressing metastasis'.

About Mestastop

Mestastop has developed three proprietary platforms, METAssay®, METSCAN®, and METVivo®, to address metastasis drug discovery and predictive diagnostics. The platforms have been validated in both prospective and retrospective clinical studies, presented in international conferences, and a PCT has been filed. Currently, the company is extending the platform into multiple epithelial carcinomas and exploring the role of approved non-oncology drugs for chronic indications of primary tumour progression.

About IBAB

IBAB is an autonomous institution set up by the Department of Electronics, IT, BT and S&T of the Government of Karnataka in 2001 as a non-profit registered Society. IBAB is a pioneering institution with a vision to be an important catalyst for the growth of the biotech, bioinformatics and related industries in Karnataka and India. It's mission is to grow into a world-class Bioinformatics and Biotechnology institute through its education, research, and entrepreneurship programmes. The institute has many firsts to its name. Its educational programmes currently include a masters' in biotechnology and bioinformatics (with a 100% placement rate, with the best of academic and corporate institutions), a soon-to-be-launched masters' in big data biology, a PhD programme (including industrial PhDs), and a large bouquet of short-term courses. Its faculty conduct research in a wide variety of areas. It also incubated 30 start-ups to date.

Original Source of the original story >> Mestastop Solutions starts collaboration with IBAB, Bangalore to create novel animal models for metastasis